July 2026 · Lausanne, Switzerland

PointFit Technology Presents Breakthrough Sweat Biosensor Data at ECSS 2026 in Lausanne

Validation trial results reveal exceptional sweat lactate correlation at Europe's premier sports science congress

LAUSANNE, SWITZERLAND – July 2026 – PointFit Technology recently took the stage at the 31st European College of Sport Science (ECSS) Annual Congress, held at the SwissTech Convention Center in the Olympic Capital of Lausanne. Co-Founder & CEO Kenny Oktavius led the delegation, marking an incredible week of sports science innovation, expert collaboration, and a memorable visit to the iconic International Olympic Committee (IOC) Headquarters.

Unveiling Our Validation Trial Results

During the congress, PointFit proudly presented the findings of our latest validation trial work, completed in collaboration with Carl James and the Hong Kong Baptist University team.

The presented pilot study, titled "Exploring the Temporal Relationship Between Sweat and Blood Lactate Using a Wearable Biosensor in Cyclists," highlighted key milestones in our sensor accuracy:

  • High Metabolic Correlation: Testing on recreational cyclists revealed that after optimizing for temporal alignment, our continuous PF ACE sweat lactate data achieved an exceptional correlation of 0.9547 ± 0.0327 against traditional, discrete capillary blood lactate markers.
  • Real-Time Tracking: The study successfully proved that sweat lactate can reliably track systemic metabolic stress under personalized calibration, opening up new frontiers for non-invasive, real-time athletic monitoring.

Gallery

Kenny Oktavius at ECSS 2026 in Lausanne
Co-Founder & CEO Kenny Oktavius at the SwissTech Convention Center
View ECSS 2026 research poster (PDF)
logo Privacy policy

These statements have not been evaluated by the FDA. PointFit Sweat Sensor is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease.